Source disclosure: February 19, 2026
Veritas In Silico Inc. [130A.T]
TOKYO, Feb 19 (Pulse News Wire) – Veritas In Silico Inc. (130A.T) announced today that its board of directors has selected candidates for the upcoming annual shareholders' meeting scheduled for March 24, 2026.
All four incumbent directors will complete their terms at the conclusion of the meeting, along with current auditor Suzuki Sadayoshi. Additionally, the resignation of Suzuki Sadayoshi will trigger the appointment of Hamano Eiji as his successor. The proposed slate includes five director nominees, one auditor nominee, and one alternate auditor nominee. Among the nominees, Nakamura Shinzo, Haragawa Hirosaku, Kouda Isonao, Komina Namikinichiro, and Satou Tomoko are up for reappointment or new roles. Notably, Komina Namikinichiro and Satou Tomoko are external director candidates who, if elected, will be reported to the Tokyo Stock Exchange as independent directors. Hamano Eiji, also an external candidate, will serve as the successor to Suzuki Sadayoshi until the latter's term expires.
Meanwhile, Goto Jun will continue as the alternate auditor. Satou Tomoko was born on December 15, 1954, and brings extensive experience in pharmaceutical research and development, having held key positions at companies such as Bayer Yakuhin and MSD. She served as president of a biotech firm until February 2025 and currently advises Veritas In Silico. Hamano Eiji, born on March 22, 1958, has a background in aviation and corporate auditing, serving in leadership roles at Japan Airlines and other major corporations. He retired from his position as a regular auditor in November 2025. Upon approval, Veritas In Silico’s management structure will consist of internal and external directors and auditors, ensuring a balanced governance framework for the future.
AI-translated content. 🟢 Confidence: High See terms • Original filing